Inside the Practice: Impact of COVID-19 On Clinical Trials

Chris Labaki, MD, Research Associate in Medicine at Dana-Farber Cancer Institute, a recent study published discussing cancer clinical trials and the rising accrual rates after COVID-19. In the interview, Labaki discussed the results observed between the 2 cohorts, what clinicians have learned from this pandemic, and where he hopes to see this research advance in the future.